We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQIX icon
101
Equinix
EQIX
$103B
$2.87M 0.21%
3,750
-844
-18% -$662K
UPS icon
102
United Parcel Service
UPS
$88.9B
$2.87M 0.21%
+28,941
New +$2.71M
GIFI
103
DELISTED
Gulf Island Fabrication
GIFI
$2.86M 0.21%
+238,633
New +$2.4M
SRTA
104
Strata Critical Medical Inc
SRTA
$512M
$2.85M 0.21%
592,379
-7,842
-1% -$37.9K
HYG icon
105
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$2.83M 0.21%
35,116
+14,018
+66% +$1.13M
UBER icon
106
Uber
UBER
$153B
$2.76M 0.2%
33,787
+1,045
+3% +$94.1K
MCHP icon
107
Microchip Technology
MCHP
$46B
$2.76M 0.2%
+43,250
New +$2.67M
LENZ
108
LENZ Therapeutics
LENZ
$168M
$2.72M 0.2%
+170,224
New +$4.96M
LW icon
109
Lamb Weston
LW
$7.19B
$2.72M 0.2%
+65,000
New +$3.83M
PGEN icon
110
Precigen
PGEN
$2.59B
$2.72M 0.2%
649,974
+380,463
+141% +$1.47M
GH icon
111
Guardant Health
GH
$22.6B
$2.71M 0.2%
26,550
-942
-3% -$84.3K
RBLX icon
112
Roblox
RBLX
$27B
$2.71M 0.2%
33,411
-17,011
-34% -$1.81M
WFRD icon
113
Weatherford International
WFRD
$6.22B
$2.7M 0.2%
34,551
-11,442
-25% -$831K
CHTR icon
114
Charter Communications
CHTR
$18.2B
$2.62M 0.19%
12,535
+515
+4% +$116K
ROIV icon
115
Roivant Sciences
ROIV
$26.2B
$2.62M 0.19%
120,515
+39,435
+49% +$778K
COGT icon
116
Cogent Biosciences
COGT
$7.24B
$2.57M 0.19%
72,378
-64,903
-47% -$1.82M
IONS icon
117
Ionis Pharmaceuticals
IONS
$9.4B
$2.57M 0.19%
32,481
-4,812
-13% -$362K
ANET icon
118
Arista Networks
ANET
$238B
$2.56M 0.19%
19,509
+13,103
+205% +$1.8M
GLPI icon
119
Gaming and Leisure Properties
GLPI
$12.8B
$2.54M 0.19%
56,805
+31,892
+128% +$1.41M
IBIT icon
120
iShares Bitcoin Trust
IBIT
$48.4B
$2.53M 0.19%
50,903
-166,195
-77% -$9.44M
GNW icon
121
Genworth Financial
GNW
$3.71B
$2.51M 0.18%
277,533
+12,018
+5% +$105K
SBAC icon
122
SBA Communications
SBAC
$19.5B
$2.5M 0.18%
12,900
+4,210
+48% +$813K
MGNI icon
123
Magnite
MGNI
$3.55B
$2.47M 0.18%
152,200
+38,551
+34% +$640K
NUE icon
124
Nucor
NUE
$62.1B
$2.46M 0.18%
15,073
+12,907
+596% +$1.94M
BFIN
125
DELISTED
BankFinancial
BFIN
$2.43M 0.18%
202,872
+45,191
+29% +$534K

Similar funds

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.